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2Abstract
The phenolic profile and the antibacterial activity against pathogenic commensal 
vaginal bacteria exhibited by different fractions of the acetone extract of heather was 
assessed. The acetone extract of Calluna vulgaris (L.) Hull was fractionated by silica 
gel column chromatography through an eluent system of increasing polarity, obtaining 
10 different fractions (Fr 1 to Fr 10). The phenolic profile was analyzed by HPLC-
DAD-ESI/MS. Type B (epi)catechin dimers, (-)-epicatechin and (+)-catechin were the 
main phenolic compounds present in the fractions. The antibacterial activity was also 
analyzed against pathogenic bacteria and the effect in the beneficial microflora was also 
accessed. Some of the obtained fractions revealed the capacity to inhibit pathogenic 
microorganisms without affecting the beneficial microflora, especially Fr 7 and Fr 8. 
For instance, Neisseria gonorrhoeae was inhibited by both of the fractions, while Fr 7 
was more active against Klebsiella pneumoniae and Morganella morganii, and Fr 8 
against methicillin resistance Staphylococcus aureus (MRSA) and methicillin 
susceptible Staphylococcus aureus (MSSA), without affecting Lactobacillus strains. 
This study corroborates the therapeutic use of this matrix in traditional medicine. 
Keywords: Calluna vulgaris (L.) Hull, acetone extract fractions, phenolic profile, 
antibacterial activity, vaginal microbiota.
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31. Introduction
The availability of effective antibacterial agents is becoming lower as result of the 
capacity that pathogenic microorganisms have developed to create different forms of 
resistance. Thus, the search for new and effective antibacterial agents has been 
considered a global priority.1,2 In the search for new antimicrobial agents, particular 
attention has been given to natural products as result of their richness and diversity in 
phytochemical compounds with high bioactive properties. Among the natural resources, 
medicinal plants have been the most studied based on the ancient ethnopharmacological 
knowledge. These studies have scientifically demonstrated the therapeutic potential for 
which these plants have been used over the time.3,4
Calluna vulgaris (L.) Hull (commonly known as Scotch heather, common heather and 
ling) is the only species of Calluna genus (Ericaceae). It is a small shrub native to 
Europe and North Africa and was introduced in other countries such United States of 
America, Australia and Canada. Infusions and decoctions are the most described forms 
of consumption of this shrub in folk medicine. This shrub exhibits a broad spectrum of 
biological activities being used for the treatment of rheumatic pain and arthritis 5,6 and 
as a tranquilizer and sedative.7,8 Moreover, this matrix is used for the treatment of 
infections related to the urinary tract, that highlights the medicinal effects as result of 
their anti-inflammatory, depurative, diuretic and antiseptic properties.5,6,9,10 Extracts 
obtained from the inflorescences have demonstrated antibacterial activity against 
several bacterial strains, some of which were clinical isolates responsible for urinary 
infections, such as Escherichia coli, Klebsiella penumoniae, Pseudomonas aeruginosa 
and Neisseria gonoeehoeae.11
Extracts obtained from the different plant parts of heather (i.e. flowers, leaves, roots, 
and seeds) have been studied as an attentive to prove their folk medicine uses through 
Page 3 of 27 Food & Function
Fo
od
&
Fu
nc
tio
n
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
17
 A
pr
il 
20
19
. D
ow
nl
oa
de
d 
by
 R
O
BE
RT
 G
O
RD
O
N
 U
N
IV
ER
SI
TY
 o
n 
4/
21
/2
01
9 
12
:0
7:
07
 P
M
. 
View Article Online
DOI: 10.1039/C9FO00415G
4scientific methodologies. Different therapeutic properties such as antioxidant,6,12 anti-
inflammatory,6,10 anti-nociceptive,10 cytotoxic,13 antiviral 14 and enzymatic inhibition 6 
were studied and scientifically validated. 
The phytochemical composition contains a large variety of molecules, resulting from 
both primary and secondary metabolism. In recent studies, it was possible to identify 
the four isoforms of tocopherol, with α-tocopherol as the major compound 9,11; as also 
the presence of some organic acids such as oxalic, quinic, ascorbic and citric acids.11 
Moreover, myricetin-3-O-glucoside and myricetin-O-rhamnoside were the main 
phenolic compounds found in acetone, methanol and aqueous extracts of heather 
inflorescences.11 These class of bioactive molecules have been described as the 
compounds responsible for the mentioned biological properties found in this species.6,12 
The content in phenolic compounds can be influenced by the environmental conditions, 
such as the stress level that plants are subjected during their development, by the 
altitude and by the harvest season.15 The study of the influence of altitude in terms of 
bioactive compounds, have demonstrated that plants growing in lower altitudes present 
lower amounts of phenolic compounds and, consequently lower antioxidant capacity.16 
Extracts of heather roots, obtained by an hydromethanolic (80:20) extraction, revealed 
the presence of catechins and procyanidins.15 Triterpenoids such as ursolic and 
oleanolic acids were identified in chloroform extracts of cuticular waxes of heather 
flowers and leaves and have different biological activities, particularly anti-
inflammatory activity.17
A study on the antibacterial activity of different aqueous (infusion and decoction) and 
organic extracts (n-hexane, dichloromethane, ethyl acetate, acetone and methanol) was 
recently conducted by some of the authors,11 and as result of the high demonstrated 
potential, in the present study the acetone extract was fractionated by gradient elution 
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5through column chromatography on silica gel. The resulted fractions were characterized 
for their composition in phenolic compounds and their antibacterial potential against 
pathogenic microorganisms and non-pathogenic bacteria of vaginal microflora was also 
evaluated.
2. Materials and methods
2.1. Standards and reagents
Silica gel 0.060-0.200 mm, 60 A was obtained from Acros Organics (Gell, Belgium). 
Aluminum-backed silica-gel plates Sil G/UV254, with 0.20 mm thickness, were obtained 
from Macharey-Nagel (Düren Neumann Neander, Germany). Phenolic compound 
standards were purchased from Extrasynthèse (Genay, France). Tryptic Soy Broth 
(TSB), Man Rogosa and Sharpe agar (MRS), were obtained from Biomerieux (Marcy 
l0Etoile, France). Blood agar with 7% sheep blood and MacConkey agar plates were 
acquired from Liofilchem (Roseto degli Abruzzi, Italy). The dye p-iodonitrotetrazolium 
chloride (INT) was purchased from Sigma-Aldrich (St. Louis, MO, USA). All the 
solvents used were of analytical grade, used as received and were commercially 
obtained from Fisher Scientific (Lisbon, Portugal). Water was treated with a Milli-Q 
water purification system (TGI Pure Water Systems, Greenville, SC, USA).
2.2. Plant material
The dried inflorescences of Calluna vulgaris (L.) Hull (heather) were purchased from 
the Portuguese Herbal company “Girassol”. The plant material was reduced to a fine 
powder (~20 mesh) and stored at 4 oC with protection from light until further analysis.
2.3. Fractionation of the acetone extract
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6The acetone extract (5 g) was obtained according to Mandim et al.11 being next 
dissolved in the smallest possible amount of CH2Cl2, mixed with silica gel and 
evaporated to dryness (Büchi R-20, Flawil, Switzerland). The mixture was placed on the 
top of a silica gel column and the dry-loaded extract was fractionated by gradient 
elution column chromatography,  applying the elution system: CH2Cl2; CH2Cl2/EtOAc - 
(90/10), (80/20), (70/30), (60/40), (50/50), (40/60), (30/70), (20/80), (10/90); EtOAc; 
EtOAc/acetone - (90/10), (80/20), (70/30), (60/40), (50/50), (40/60); acetone; 
acetone/MeOH - (80/20), (60/40), (10/90); MeOH; MeOH/formic acid - (99/1), (97/3), 
(95/5). This increasing polarity elution system, allowed to obtain twenty-nine fractions 
that were grouped in ten final fractions (Fr 1-10), according to their TLC profiles, being 
Fr 1 the one with lower polarity grade and Fr 10 with higher polarity. The obtained 
fractions were evaporated to dryness under reduced pressure at 40 ºC (Büchi R-20, 
Flawil, Switzerland).18 
2.4. Phenolic profile of the obtained fractions
A known mass of each fraction was re-dissolved in 20% MeOH at a final concentration 
of 20 mg/mL and filtered through a 0.22 µm nylon syringe. The phenolic compounds 
analysis was performed by High Performance Liquid Chromatography (Dionex 
Ultimate 3000 UPLC, Thermo Scientific, San Jose, CA, USA) with a diode array 
detector and coupled to mass spectrometry (Linear Ion Trap LTQ XL mass 
spectrometer, Thermo Finnigan, San Jose, CA, USA) equipped with an ESI source, 
following a methodology previously described by Bessada et al.19.
The tentative identification of these compounds was also performed according to their 
retention times, the UV and mass spectra, and with available literature information. The 
compound´s quantification was accessed by comparing the area of the chromatographic 
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7peaks using commercial calibrations curves, when possible, or calibration curves of 
similar compounds when a commercial standard was not available. The results were 
expressed in mg per g of extract.
2.5. Evaluation of the antibacterial activity
Microorganisms and growth conditions. The majority of the pathogenic bacteria were 
clinical isolates from the local health unit of Bragança, Northeast of Portugal. Four 
Gram-positive bacteria: Enterococcus faecaliis obtained from urine, methicillin resistant 
Staphylococcus aureus (MRSA) isolated from expectoration and methicillin susceptible 
Staphylococcus aureus (MSSA) from a wound exudate; and six Gram-negative bacteria: 
Morganella morganii and Pseudomonas aeruginosa both isolated from expectoration, 
Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis isolated from urine, and 
two commensal pathogenic strains: Neisseria gonorrhoeae ATCC 49226 and a variable 
Gram: Gardnerella vaginalis ATCC 14018 (Liofilchem, Roseto degli Abruzzi, Italy), 
were tested. To evaluate the effects on the vaginal microbiota, non-pathogenic 
commercial microorganisms of the vaginal microflora were tested, namely: 
Lactobacillus plantarum DSM 12028, Lactobacillus delbrueckii subs. bulgaricus LMG 
6901 and Lactobacillus casei NCTC 6375, kindly provided by the Catholic University 
of Porto. 
All the bacteria were grown in TSB/MRS culture medium according to each bacterial 
strain needs, and further incubated for 24 hours, at 37 ºC except in the cases of N. 
gonorrhoeae, G. vaginalis and the Lactobacillus strains that were incubated for 48 
hours, at 37 ºC with 10% CO2.
Minimal inhibitory concentrations (MICs): The obtained fractions were dissolved in 
TSB/MRS culture medium and 5% DMSO at a final concentration of 20 mg/mL. The 
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8fractions exhibiting the higher antibacterial activity against pathogenic bacteria were 
also tested in microorganisms belonging to the vaginal microflora: Fr 7, 8, 9 and 10.
The MICs were determined by the microdilution method and the colorimetric assay 
using INT (p-iodonitrotetrazolium chlorite, 0.2 mg/mL). Briefly, 190 µL of the stock 
solution (20 mg/mL) were added to the first well of the 96-well microplate. Successive 
dilutions were carried out over the wells containing 90 µL of culture medium. 
Afterwards, 10 µL of inoculum (1.5×108 CFU/mL) were added to all the wells 
containing the tested concentrations in the range of 0.156 to 20 mg/mL.
The microplates were further incubated in an oven (Jouan, Berlin, Germany) at 37ºC for 
24 h for E. coli, K. penumoniae, M. morganii, P. mirabilis, P. aeruginosa, E. faecalis, 
MRSA and MSSA.  In the case of N. gonorrhoeae, G. vaginalis and the Lactobacillus 
strains, the incubation was at 37 ºC for 48h with 10% CO2. Three negative controls 
were prepared (one with medium, another one with the fractions, and a third one with 
medium and antibiotic); and a positive control with medium and inoculum. Ampicillin, 
imipenem and vancomycin were the antibiotics used.
The MICs of the samples were determined after the addition of the INT (0.2 mg/mL, 40 
µL) and after incubation at 37 ºC for 30 min. The viable microorganisms reduced the 
yellow dye to pink.20 The MIC was defined as the lowest concentration that prevented 
this change and exhibited the complete inhibition of bacterial growth. 
2.6. Statistical analysis
The assays were performed in triplicate and results were expressed as mean values ± 
standard deviation (SD). The results were analyzed by variance analysis (ANOVA) and 
by a Turkey HSD test (α = 0.05). When we have less than three samples, the results 
were analyzed by t-Student test, as a form to determine the significant differences 
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9between two samples, with p = 0.05. The statistic program used to do all this analysis 
was SPSS v. 23.0 (IBM Corp., Armonk, NY, USA).
3. Results and discussion
3.1. HPLC-DAD-ESI/MS analysis of phenolic compounds identified in the obtained 
fractions 
Peak characteristics and tentative identities of the phenolic compounds are presented in 
Table 1, being the quantification of each individual compound in each fraction, showed 
in Table 2. A total of fourty-seven compounds were identified in the acetone fractions 
(Fr 1 – Fr 10), composed by one phenolic acid, sixteen flavan-3-ols ((epi)catechin, B-
type (epi)catechin dimers and trimers), two flavonones (eriodictyol derivatives), four 
flavanonols (taxifolin derivatives), and twenty-four flavonols (myricetin, quercetin, 
isorhamnetin, and kaempferol derivatives). 
Compounds 5-O-caffeoylquinic acid (4), (+)-catechin (6), myricetin-O-hexoside (16), 
myricetin-3-O-glucoside (21), quercetin-3-O-glucoside (32), quercetin-O-hexoside (33 
and 38), isorhamnetin-3-O-glucoside (35), kaempferol-O-rhamnoside (39) and 
isorhamnetin-O-rhamnoside (40) were common compounds present in the different 
organic and aqueous extracts of Calluna vulgaris (L.) Hull inflorescences.11,15 
Nevertheless, not all of the compounds ((+)-catechin (6) and kaempferol-O-rhamnoside 
(39)) were present in the acetone extract,11 due to the higher separation after the 
fractionation. 
Only one phenolic acid was found in all the fractions, being identified as 5-O-
caffeoylquinic acid (peak 4), which was positively identified in comparison with the 
commercial standard.
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10
Sixteen compounds were assigned as flavan-3-ols (i.e., catechins and procyanidins). 
These compounds were assigned based on their pseudomolecular ions and MS2 
fragmentation patterns, characterised by the formation of product ions from the 
cleavage of the interflavan bond and retro-Diels-Alder (RDA) and heterocyclic ring 
fissions (HRF) of the elementary flavan-3-ol units.21 The mass spectra evaluation does 
not allow establishing the position of the linkage between flavanol units (i.e., C4-C8 or 
C4-C6) and differentiation between isomeric catechins (e.g., catechin/epicatechin). 
Compounds (+)-catechin (6) and (-)-epicatechin (11) were positively identiﬁed 
according to their retention time, mass and UV-Vis characteristics by comparison with 
commercial standards. The remaining compounds corresponded to proanthocyanidin 
oligomers of the procyanidin class (i.e., consisting of catechin and/or epicatechin units). 
Peaks 1, 2, 3, 5, 8, 10 and 17 presented the same pseudomolecular ion [M-H]- at m/z 
577 and MS2 fragmentation patterns coherent with B-type (epi)catechin dimers (i.e., 
(epi)catechin units with C4–C8 or C4–C6 interﬂavan linkages). Characteristic product 
ions were observed at m/z 451 (-126 u), 425 (-152 u) and 407 (-152-18 u), attributable 
to the HRF, RDA and further loss of water from an (epi)catechin unit, and at m/z 289 
and 287, that could be associated to the fragments corresponding to the lower and upper 
(epi)catechin unit, respectively. Similarly, compounds 7, 12, 14, 15, 18, 19 and 22 
(pseudomolecular ions [M-H]- at m/z 865) were assigned as B-type (epi)catechin 
trimers. These compounds have been reported previously in a hydroalcoholic extract of 
different parts of C. vulgaris.9
Peaks 20, 24, 26 and 30 were assigned as taxifolin derivatives based on their UV spectra 
and the fragment at m/z 303 [taxifolin-H]-. Peaks 20 and 24 ([M-H]- at m/z 465) released 
a unique fragment at m/z 303 [taxifolin-H]- (-162 mu, loss of a hexosyl moiety). 
Taxifolin-3-O-glucoside was previously detected in flowers of C. vulgaris, and 
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11
therefore compound 20 was assigned as this compound. Peak 24 was tentatively 
identified as taxifolin-O-hexoside, due to the fact that ESI/MS analysis does not allow 
obtaining information about the nature and position of the sugar moieties. Compound 
26 ([M-H]- at m/z 303) was positively identified as taxifolin. Similar assumptions were 
performed for compounds 9 and 23 ([M-H]- at m/z 449) being tentatively identified as 
eriodictyol-O-hexoside. To the best of our knowledge, these compounds were not 
previously identified in C. vulgaris.
The remaining peaks corresponded to flavonol glycoside derivatives deriving from 
quercetin (peaks 27, 32, 33, 34, 36, 37, 38, 42, 43, 44, 45 and 47), kaempferol (peak 
39), myricetin (13, 16, 21, 25, 28, 29 and 31) and isorhamnetin (peaks 35, 40, 41 and 
46) (Table 1). Compound 32 (quercetin-3-O-glucoside) and 35 (isorhamnetin-3-O-
glucoside) were positively identified.
Peaks 27, 33 and 38 ([M-H]- at m/z 463) released a fragment at m/z 301 [quercetin-H]- (-
162 mu, loss of a hexosyl moiety) being all identified as quercetin-O-hexoside 
derivatives. Compounds 34 ([M-H]- at m/z 433), 36 and 37 ([M-H]- at m/z 433), 
presented a MS2 fragment corresponding to the loss of a pentosyl (-132 mu) and a 
rhamnosyl (-146 mu) moiety, respectively, being assigned as quercetin-O-pentoside and 
quercetin-O-rhamnoside. Similarly, compounds 13, 16, 21, 25, 28 and 31 ([M-H]- at m/z 
479) and 29 ([M-H]- at m/z 463) were identified as myricetin-O-hexoside and myricetin-
O-rhamnoside, respectively. Compounds 39 ([M-H]- at m/z 431) and 40 ([M-H]- at m/z 
461) were assigned based on their pseudomolecular ions using a similar reasoning as for 
quercetin derivatives, being identified as kaempferol-O-rhamnoside and isorhamnetin-
O-rhamnoside, respectively. No information about the identity of the sugar moieties and 
location onto the aglycone could be obtained. Peaks 42, 43 and 44 possessed the same 
pseudomolecular ion ([M-H]- at m/z 639) and were identified as quercetin-O-(feruloyl)-
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glucoside, due to the observation of a product ion at m/z 463, from the loss of feruloyl 
residue (176 u), as well as the late elution, since the presence of the hydroxycinnamoyl 
residue implies a decrease in polarity. Similarly, compounds 46 ([M-H]- at m/z 609) and 
47 ([M-H]- at m/z 593) were identified as isorhamnetin-O-(caffeoyl)-pentoside and 
quercetin-O-(p-coumaroyl)-rhamnoside, respectively.
Finally, for compounds 30 ([M-H]- at m/z 575), 41 ([M-H]- at m/z 583) and 45 ([M-H]- 
at m/z 567) no precise identification of the moieties was possible, therefore they were 
identified as taxifolin, isorhamnetin and quercetin derivatives.
Flavonol derivatives have been extensively reported in different parts and extracts of C. 
vulgaris (L.) Hull.9,10 To the best of our knowledge, some of the identified compounds, 
such B type (epi)catechin dimer and trimer, eriodyctiol-O-hexoside, quercetin-O-
(feruloyl)-hexoside, isorhamnetin-O-(caffeoyl)-pentoside and quercetin-O-(p-
coumaroyl)-rhamnoside, have not been reported previously in this species. Fr 4 
presented the highest concentration in some of the identified compounds, followed by 
Fr 7 > Fr 8 > Fr 9 > Fr 10 > Fr 6 > Fr 5 = Fr 1 > Fr 3 = Fr 2, being flavan-3-ols, such 
as B-type (epi)catechin dimer, (-)-epicatechin and (+)-catechin the most abundant 
compounds. Figure 1 represents the phenolic profile of the acetone fraction Fr 8.
3.2. Antibacterial activity of the obtained fractions
Table 3 presents the MIC values (mg/mL) of the 10 fractions tested against the 
pathogenic and non-pathogenic bacteria. 
Pathogenic commensal bacteria: All the analyzed fractions revealed activity against all 
the tested bacterial strains. In general, the exhibited activity is higher in the most polar 
fractions, suggesting that the compounds with higher polarity present in the acetone 
extract are the major contributors to the antibacterial potential.
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Pseudomonas aeruginosa was the most resistant microorganism (MIC values ranging 
from 5 to >20 mg/mL), while methicillin susceptible Staphylococcus aureus (MSSA) 
was the most susceptible one (MIC values ranging from 0.15 to 20 mg/mL). By 
comparing the results of fractions with the antibiotics used, the fractions Fr 6, Fr 7, Fr 
8, Fr 9 and Fr 10 revealed stronger results than ampicillin against Klebsiella 
pneumoniae, Morganella morganii and P. aeruginosa.
Fr 7, Fr 8, Fr 9, and Fr 10 were the ones that benefice more with the fractionation 
process, showing higher antibacterial activity presenting the lower MIC values (MIC 
values= 0.15 - >20 mg/mL). The opposite occurs with the fraction’s Fr 4 and Fr 5, that 
revealed higher MIC values and, consequently, lower antibacterial activity (MIC values 
ranging from 20 to >20 mg/mL).
When comparing the results between the antibacterial activity of the acetone extract, 
previously studied,11 with the correspondent fractions, it can be seen that the 
fractionation process wasn’t benefic against some of the analyzed bacterial strains and 
to all the fractions obtained. Fr 1, Fr 4 and Fr 5 revealed higher MIC values to all 
pathogenic bacteria (MIC values ranging from 10 to >20 mg/mL) when compared to the 
acetone extract (MIC values ranging from 0.6 to 20 mg/mL). The same occurs with 
fractions Fr 7, Fr 8, Fr 9 and Fr 10 against P. aeruginosa and Enterococcus faecalis, 
with similar or higher MIC values in comparison to the extract (MIC values ranging 
from 5 to >20 mg/mL for the fractions and 2.5 to 5 mg/mL for the extract). Fr 7 and Fr 
10 demonstrated also lower potential against methicillin resistant Staphylococcus 
aureus (MRSA) (MIC values ranging from 1.25 to 2.25 mg/mL against 0.6 mg/mL of 
the extract). Finally, Fr 6 demonstrated lower activity against P. aeruginosa, E. 
faecalis, MSSA and MRSA (MIC values of 10 mg/mL against the 0.6 to 5 mg/mL 
revealed by the acetone extract). 
Page 13 of 27 Food & Function
Fo
od
&
Fu
nc
tio
n
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
17
 A
pr
il 
20
19
. D
ow
nl
oa
de
d 
by
 R
O
BE
RT
 G
O
RD
O
N
 U
N
IV
ER
SI
TY
 o
n 
4/
21
/2
01
9 
12
:0
7:
07
 P
M
. 
View Article Online
DOI: 10.1039/C9FO00415G
14
On the other hand, it can be seen that the fractionation process was benefic for some of 
the tested fractions. Fr 7 – Fr 10 revealed higher potential against Escherichia coli 
(MIC value of 2.5 mg/mL, against the 5 mg/mL of the extract), K. pneumoniae and M. 
morganii (MIC 1.25 – 2.5 mg/mL in comparison to 5 mg/mL of the extract) and against 
Proteus mirabillis (MIC values ranging from 2.5 to 10 mg/mL for the fractions and 10 
mg/mL for the extract). Fr 6 exhibited higher potential only against P. mirabillis (MIC 
value of 5 mg/mL against the 10 mg/mL demonstrated by the extract). Fr 8 and Fr 9 
revealed also higher antibacterial activity to MSSA (MIC value of 0.15 mg/mL in 
comparison to the 1.25 mg/mL demonstrated by the extract). 
Both of the commercial pathogenic vaginal bacterial strains, Neisseria gonorrhoeae and 
Gardnerella vaginallis, seem to be strongly inhibited by the obtained fractions. Fr 8 
presented a MIC value of 0.625 mg/mL, and Fr 7, Fr 9 and Fr 10 exhibited a MIC 
value of 1.25 mg/mL; lower MIC values than the one exhibited by the acetone extract 
against these strains (MIC = 2.5 mg/mL), in the case of N. gonorrhoeae. For G. 
vaginallis, Fr 7 and Fr 10 revealed a MIC value of 2.5 mg/mL and Fr 8 and Fr 9 a 
MIC value of 1.25 mg/mL, when compared with the MIC of 5 mg/mL showed by the 
acetone extract.11 
The antibacterial properties of heather extracts were already related but, in some of the 
studies, heather did not revealed a promising activity; this fact can be justified by the 
studied parts of this shrub, mostly roots and seems.5 Several authors reported that there 
was no inhibition by this matrix in microorganisms such as E. coli, K. pneumoniae,22 
MRSA, P. mirabilis,5 and P. aeruginosa,5,22 contrarily to what is reported in the present 
work.
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Pathogenic and non-pathogenic vaginal bacteria: The bacteria species belonging to the 
vaginal microbiota have the capacity to defend the organism of possible infections, 
through of limitation of the growth of potentially harmful microorganisms. Due to this 
fact, it is desirable that the usual antibiotics interfere the lowest possible with the 
benefic microflora, e.g. Lactobacillus sp. and, at the same time, have the capacity to 
inhibit or even kill the pathogenic microorganisms. 
As a result of the higher antimicrobial activity exhibited by Fr 7, Fr 8, Fr 9 and Fr 10 
against the pathogenic bacteria, their effects on the benefic bacteria belonging to the 
vaginal microbiota was accessed. The four fractions presented a very similar activity, 
with MICs in the range of 0.625 and 2.5 mg/mL. Only Fr 7 and Fr 8 revealed the 
lowest MIC values to N. gonorrhoeae, the vaginal pathogenic microorganism 
comparatively to the beneficial Lactobacillus: Fr 7, presented a MIC value of 1.25 
mg/mL against N. gonorrhoeae and 2.5 mg/mL against the Lactobacillus. In its turn, Fr 
8 showed a MIC of 0.625 mg/mL against N. gonorrhoeae and 1.25 mg/mL against the 
Lactobacillus strains. In both cases, the MIC values are lower comparatively to the 
acetone extract, revealing a stronger potential provided by the fractionation process. The 
stronger antibacterial potential showed by the Fr 7 and 8 is consistent the higher 
contents in total phenolic compounds identified in these fractions (Table 2).
 From Table 3 it is possible to suggest that fraction 7 was able to inhibit the pathogenic 
K. pneumonia, M. morganii and N. gonorrhoeae (MIC value of 1.25 mg/mL) without 
affecting the vaginal microbiota (MIC value of 2.5 mg/mL). In its turn, Fr 8 can inhibit 
N. gonorrhoeae and almost all the Gram-positive bacteria (MIC values ranging from 
0.15 to 0.625 mg/mL), also causing no changes in the vaginal microbiota (MIC value of 
1.25 mg/mL).
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All the tested fractions revealed lower MIC values when compared to the ones exhibited 
by the acetone extract,11 which showed MIC values of 10 mg/mL against Lactobacillus 
delbrueckii and Lactobacillus casei, and 20 mg/mL against Lactobacillus plantarum. 
Thus, it is possible to conclude that Fr 7 and Fr 8 were the most promising fractions 
obtained from the acetone extract of C. vulgaris, since the antibacterial activity was 
significantly improved, highlighting the capacity to inhibit pathogenic bacteria with no 
interference on the benefic strains. It is described in the literature that the phenolic 
compounds can inhibit bacteria by different mechanisms of action such as the inhibition 
of DNA synthesis, resulting from an effect associated with the inhibition of RNA and 
protein synthesis, especially in the case of Gram-positive bacteria, or through the 
membranes alteration in the case of the Gram-negative strains.23 
In another report about the antimicrobial activity of naphthol derivatives, the authors 
described that these compounds are able to be transformed into quinone methides 
intermediates during the metabolic processes, and, these compounds act like alkylating 
agents and inhibitors of serine proteases and -lactamases.24
Fractionation studies should be performed in future works, as a way to identify the 
compounds responsible for the demonstrated activity and the synergic and/or 
antagonistic effects that may be associated. Moreover, the mechanisms of action of 
these compounds should also be deeply investigated to better understand their 
interaction with the bacterial strains. To the best of our knowledge, the antibacterial 
effects of the fractionated acetone extract from heather constituents has never been 
described. 
4. Conclusions
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The antibacterial potential for which C. vulgaris is consumed in folk medicine was 
studied through scientific methods. The acetone extract was previously tested revealing 
the highest potential, therefore, being chosen to be fractionated through a silica gel 
column chromatography. The 10 fractions obtained were analyzed relatively to their 
phenolic composition and antibacterial potential using pathogenic and non-pathogenic 
bacterial strains. It was possible to identified 47 phenolic compounds: 1 phenolic acid, 
16 fravan-3-ol, 2 flavanones and 24 flavanols. Type B (epi)catechin dimers, (-)-
epicatechin and (+)-catechin were the major compounds found. 
Moreover, the fractions presenting the highest concentration of phenolic compounds (Fr 
7 and 8) were also the ones that presented the highest antimicrobial capacity. When 
comparing the fractions with the acetone extract, the fractionation process significantly 
increased the antibacterial activity against the pathogenic microorganisms, without 
affecting the Lactobacillus strains of the vaginal microflora. 
This study reports, for the first time, the improvement of the antibacterial capacity by 
the fractionation of the acetone extract from heather, corroborating the use of this plant 
in the folk medicine for antimicrobial purposes. It should also be highlighted the 
capacity of fractions 7 and 8, to inhibit the pathogenic bacteria and protect human health 
through vaginal microbiome preservation. 
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Table 1 Peak characteristics and tentative identification of phenolic compounds of the fractions of the acetone extract of C. vulgaris (L.) Hull.
Peak Rt (min) λmax (nm) [M-H]- (m/z) MS2 (m/z) Tentative identification
1 5.19 279 577 425(100), 289(15) B type (epi)catechin dimer 
2 5.51 279 577 425(100), 289(15) B type (epi)catechin dimer
3 6.19 279 577 425(100), 289(15) B type (epi)catechin dimer
4 6.26 345 353 191(100), 179(11), 173(7), 161(15), 135(6) 5-O-Caffeoylquinic acid
5 6.33 279 577 425(100), 289(15) B type (epi)catechin dimer
6 6.99 279 289 245(100),203(12),137(5) (+)-Catechin
7 7.5 280 865 711(100), 573(19), 451(24), 411(16), 289(5), 287(2) B type (epi)catechin trimer
8 7.61 279 577 425(100), 289(15) B type (epi)catechin dimer
9 8.12 281 449 287(100) Eriodyctiol-O-hexoside
10 8.35 279 577 425(100), 289(15) B type (epi)catechin dimer
11 9.57 279 289 245(100),203(15),137(5) (-)-Epicatechin
12 9.85 280 865 711(100), 573(22), 451(25), 411(18), 289(6), 285(2) B type (epi)catechin trimer
13 10.51 281 479 317(100) Myricetin-O-hexoside
14 10.71 280 865 711(100), 573(19), 451(24), 411(16), 289(5), 285(2) B type (epi)catechin trimer
15 11.23 280 865 711(100), 573(19), 451(24), 411(16), 289(5), 285(2) B type (epi)catechin trimer
16 11.27 281 479 317(100) Myricetin-O-hexoside
17 12.36 279 577 425(100), 289(12) B type (epi)catechin dimer
18 12.47 280 865 711(100), 573(19), 451(24), 411(16), 289(5), 285(2) B type (epi)catechin trimer
19 12.89 280 865 711(100), 573(19), 451(24), 411(16), 289(5), 285(2) B type (epi)catechin trimer
20 14.27 291 465 303(74),285(100) Taxifolin-3-O-hexoside
21 14.97 281 479 317(100) Myricetin-3-O-glucoside
22 15.45 280 865 577(45),425(100), 289(12) B type (epi)catechin trimer
23 15.47 281 449 287(100) Eriodyctiol-O-hexoside
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24 16.14 291 465 303(74),285(100) Taxifolin-O-hexoside
25 17.14 281 479 317(100) Myricetin-O-hexoside
26 17.35 285 303 285(100) Taxifolin
27 17.49 355 463 301(100) Quercetin-O-hexoside
28 17.52 281 479 317(100) Myricetin-O-hexoside
29 17.68 281 463 317 (100) Myricetin-O-rhamnoside
30 17.99 280 575 303(40),285(100) Taxifolin derivate
31 18.25 281 479 317(100) Myricetin-O-hexoside
32 18.5 355 463 301(100) Quercetin-3-O-glucoside
33 19.09 354 463 301(100) Quercetin-O-hexoside
34 21.47 353 433 301(100) Quercetin-O-pentoside
35 22.52 347 477 315(100) Isorhamnetin-3-O-glucoside
36 22.55 347 447 301(100) Quercetin-O-rhamnoside
37 23.52 342 447 301(100) Quercetin-O-rhamnoside
38 26.39 355 463 301(100) Quercetin-O-hexoside
39 27.33 343 431 285(100) Kaempferol-O-rhamnoside
40 28.4 346 461 315(100) Isorhamnetin-O-rhamnoside
41 30.15 354 583 315(100) Isorhamnetin derivate
42 30.93 308 639 463(100),301(32) Quercetin-O-(feruloyl)-hexoside
43 31.36 306 463 301(100) Quercetin-O-(feruloyl)-hexoside
44 31.36 308 639 463(100),301(32) Quercetin-O-(feruloyl)-hexoside
45 33.49 352 567 301(100) Quercetin derivate
46 34.67 336 609 315(100) Isorhamnetin-O-(caffeoyl)-pentoside
47 37.59 326 593 301(100) Quercetin-O-(p-coumaroyl)-rhamnoside
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Table 2 Quantification of individual phenolic compounds present in each fraction tested (mg/g of fraction; mean ± standard deviation).
Peak Fr 1 Fr 2 Fr 3 Fr 4 Fr 5 Fr 6 Fr 7 Fr 8 Fr 9 Fr 10
1a 1.444 ± 0.003e n.d. 1.100 ± 0.008e 206 ± 2a 17.2 ± 0.6c 8.5 ± 0.2d 31.6 ± 0.2b n.d. n.d. n.d.
2 a 0.755 ± 0.005e n.d. 3.04 ± 0.01d 101.1 ± 0.3a 7.73 ± 0.02c 3.60 ± 0.01d 26.4 ± 0.7b n.d. n.d. n.d.
3 a n.d. n.d. n.d. n.d. n.d. n.d. 11.68 ± 0.06 n.d. n.d. n.d.
4 b 1.29 ± 0.03a 0.204 ± 0.002c n.d. n.d. n.d. n.d. n.d. n.d. n.d. 0.90 ± 0.02b
5 a n.d. n.d. 0.31 ± 0.01d 20.2 ± 2.5a 1.526 ± 0.002c n.d. n.d. 4.50 ± 0.07b n.d. n.d.
6 a n.d. n.d. n.d. n.d. n.d. 12.1 ± 0.3* 48.3 ± 0.8* n.d. n.d. n.d.
7 a 0.19 ± 0.04* n.d. n.d. n.d. n.d. n.d. n.d. 8.4 ± 0.3* n.d. n.d.
8 a n.d. n.d. 0.85 ± 0.03* n.d. n.d. n.d. 11.69 ± 0.08* n.d. n.d. n.d.
9 a n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 1.10 ± 0.01
10 a n.d. n.d. n.d. n.d. n.d. 10.32 ± 0.01 10.92 ± 0.01 n.d. n.d. n.d.
11 a n.d. n.d. n.d. n.d. n.d. 7.88 ± 0.03* 62.37 ± 1.52* n.d. n.d. n.d.
12 a n.d. 0.105 ± 0.002c n.d. n.d. n.d. n.d. n.d. 32.6 ± 0.6a 13.0 ± 0.2b n.d.
13 c n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 4.5 ± 0.1
14 a n.d. n.d. n.d. n.d. n.d. n.d. 45 ± 1a 27 ± 1b 8.0 ± 0.2c n.d.
15 a n.d. n.d. n.d. n.d. n.d. n.d. 10.3 ± 0.3 n.d. n.d. n.d.
16 c n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 4.4 ± 0.2
17 a n.d. n.d. n.d. n.d. n.d. n.d. n.d. 11.4 ± 0.4 n.d. n.d.
18 a n.d. n.d. n.d. n.d. n.d. n.d. 6.5 ± 0.2 n.d. n.d. n.d.
19 a 7.24 ± 0.06b n.d. n.d. n.d. n.d. 0.70 ± 0.03c 11.67 ± 0.04a n.d. n.d. n.d.
20 d n.d. n.d. n.d. n.d. n.d. n.d. n.d. 7.26 ± 0.03b 44 ± 1a 3.14 ± 0.02c
21 c n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 9.8 ± 0.4
22 a n.d. n.d. n.d. n.d. n.d. 1.45 ± 0.01 n.d. n.d. n.d. n.d.
23 a n.d. n.d. n.d. n.d. n.d. n.d. 18.56 ± 0.05 n.d. n.d. n.d.
24 d 0.84 ± 0.01* n.d. n.d. n.d. n.d. n.d. n.d. n.d. 3.78 ± 0.05* n.d.
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25 c 2.280 ± 0.005 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
26 d 4.1 ± 0.1b n.d. n.d. n.d. n.d. 3.18 ± 0.09c 11.2 ± 0.2a n.d. n.d. n.d.
27 e n.d. 0.4589 ± 0.0004a n.d. 0.25 ± 0.01c 0.301 ± 0.002b n.d. n.d. n.d. n.d. n.d.
28 c n.d. n.d. n.d. n.d. n.d. n.d. n.d. 4.64 ± 0.08 n.d. n.d.
29 c n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 4.9 ± 0.1
30 d n.d. n.d. n.d. n.d. n.d. n.d. 7.4 ± 0.2 n.d. n.d. n.d.
31 c n.d. n.d. n.d. n.d. n.d. n.d. n.d. 4.3 ± 0.2 4.6 ± 0.1 n.d.
32 e n.d. n.d. n.d. n.d. 0.240 ± 0.002c n.d. n.d. n.d. 5.4 ± 0.2b 18.696 ± 0.008a
33 e n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 0.84 ± 0.03
34 e n.d. n.d. n.d. n.d. 0.234 ± 0.002c n.d. n.d. n.d. 1.80 ± 0.04a 0.89 ± 0.03b
35 e n.d. n.d. n.d. n.d. 0.234 ± 0.002* 0.804 ± 0.001* n.d. n.d. n.d. n.d.
36 e n.d. n.d. n.d. n.d. n.d. n.d. n.d. 29.4 ± 0.3a 20.0 ± 0.1b 2.07 ± 0.08c
37 e n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 2.4 ± 0.1 n.d.
38 e n.d. n.d. n.d. n.d. n.d. n.d. n.d. 3.745 ± 0.004 3.8 ± 0.2 n.d.
39 e n.d. n.d. n.d. n.d. n.d. n.d. 0.529 ± 0.002* 2.13 ± 0.03* n.d. n.d.
40 e n.d. n.d. n.d. n.d. n.d. n.d. n.d. 4.37 ± 0.04* 1.26 ± 0.04* n.d.
41 e n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 1.15 ± 0.02 n.d.
42 e n.d. n.d. n.d. n.d. n.d. n.d. n.d. 1.39 ± 0.04 n.d. n.d.
43 e n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 1.77 ± 0.05* 0.833 ± 0.005*
44 e n.d. n.d. n.d. n.d. n.d. n.d. n.d. 1.62 ± 0.04 1.55 ± 0.01 n.d.
45 e n.d. n.d. n.d. n.d. n.d. n.d. n.d. 1.95 ± 0.02 1.31 ± 0.06 n.d.
46 e n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 0.84 ± 0.02 0.93 ± 0.01
47  e n.d. n.d. n.d. n.d. n.d. n.d. n.d. 1.11 ± 0.05* 0.87 ± 0.02* n.d.
TPC 23.55 ± 0.03h 0.768 ± 0.005j 5.29 ± 0.06i 327 ± 4a 27.4 ± 0.6g 48.5 ± 0.3f 174 ± 3b 146 ± 1c 116 ± 2d 58 ± 7e
n.d. – not detected; calibration curves: a catechin (y = 84950x – 23200, R2 = 1); b chlorogenic acid (y = 168823x – 161172, R2 = 0.999); c myricetin (y = 23287x – 581708, R2 = 0.9988); d taxifolin (y = 
203766x – 208383, R2 = 1); e quercetin 3-O-glucoside (y = 34843x – 160173, R2 = 0.9988); Different letters corresponded to significate differences (p < 0.05).*Means statistical differences obtained by a t-
student test.
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Table 3 Antibacterial activity of fractions of the acetone extract against pathogenic and non-pathogenic bacteria.
Fr 1 Fr 2 Fr 3 Fr 4 Fr 5 Fr 6 Fr 7 Fr 8 Fr 9 Fr 10 Ampicillin(20 mg/mL)
Imipenem
(1 mg/mL)
Vancomycin
(1 mg/ml)
Pathogenic
MIC MIC MBC MIC MBC MIC MBC
Gram-negative
Escherichia coli >20 >20 >20 >20 >20 2.5 2.5 2.5 2.5 2.5 <0,15 <0.15 <0.0078 <0.0078 n.t. n.t.
Klebsiella pneumoniae >20 >20 >20 >20 >20 2.5 1.25 1.25 2.5 2.5 10 20 <0.0078 <0.0078 n.t. n.t.
Morganella morganii >20 >20 >20 20 20 2.5 1.25 1.25 2.5 2.5 20 >20 <0.0078 <0.0078 n.t. n.t.
Proteus mirabilis >20 >20 >20 >20 >20 2.5 5 2.5 2.5 5 <0,15 <0.15 <0.0078 <0.0078 n.t. n.t.
Pseudomonas aeruginosa >20 >20 >20 >20 >20 5 5 5 >20 >20 >20 >20 0.5 1 n.t. n.t.
Neisseria gonorrhoeae n.t. n.t. n.t. n.t. n.t. n.t. 1.25 0.625 1.25 1.25 <0,15 <0.15 n.t. n.t. n.t. n.t.
Gram-positive
Enterococcus faecalis 5 20 20 20 20 5 5 5 5 5 <0,15 <0.15 n.t. n.t. <0.0078 <0.0078
MRSA >20 >20 20 >20 20 5 2.5 0.625 0.625 1.25 <0,15 <0.15 n.t. n.t. <0.0078 <0.0078
MSSA 5 20 20 20 20 5 2.5 0.15 0.15 0.39 <0,15 <0.15 n.t. n.t. 0.25 0.5
Variable Gram
Gardnerella vaginallis n.t. n.t. n.t. n.t. n.t. n.t. 2.5 1.25 1.25 2.5 <0,15 <0.15 n.t. n.t. n.t. n.t.
Non-pathogenic – bacteria
Lactobacillus delbrueckii n.t. n.t. n.t. n.t. n.t. n.t. 2.5 1.25 1.25 2.5 <0.15 <0,15 n.t. n.t. n.t. n.t.
Lactobacillus casei n.t. n.t. n.t. n.t. n.t. n.t. 2.5 1.25 1.25 2.5 <0.15 <0,15 n.t. n.t. n.t. n.t.
Lactobacillus plantarum n.t. n.t. n.t. n.t. n.t. n.t. 2.5 1.25 1.25 1.25 <0.15 <0,15 n.t. n.t. n.t. n.t.
MIC correspond to the minimum inhibitory concentration; MBC values correspond to the minimum bactericidal concentration; MIC and MBC values are in mg/mL; MRSA –methicillin resistant Staphylococcus aureus; MSSA –methicillin 
susceptible Staphylococcus aureus; n.t. – not tested
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Figure 1. Phenolic profile of Fr 8 recoded at 280 nm (A) and 370 nm (B).
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Phenolic profile and effects of the acetone fractions obtained from the 
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pathogenic bacteria
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